August 31, 2014 7:47 AM ET


Company Overview of Resolvyx Pharmaceuticals, Inc.

Executive Profile

Per Gjorstrup M.D., Ph.D.

Co-Founder, Chief Medical Officer and Member of Scientific Advisory Board, Resolvyx Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships


Per Gjorstrup, MD, PhD is a Co-Founder of Resolvyx Pharmaceuticals, Inc. and serves as its Chief Medical Officer. Mr. Gjorstrup served as Chief Scientific Officer of Resolvyx Pharmaceuticals, Inc. until April 2009. He has over 25 years of experience in research and development with pharmaceutical and biotechnology companies, including Chief Medical Officer at Micromet, Munich, Germany. He served as Section Leader, Pharmacology of Astra (Astra-Zeneca). He served as Head ...

Corporate Headquarters

25 First Street
Cambridge, Massachusetts 20141

United States

Phone: 781-541-5045
Fax: 781-541-5046

Board Members Memberships

There is no Board Members Memberships data available.


Lund University
Lund University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Resolvyx Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at